Neovasc (NSDQ:NVCN) said last week that it’s looking to raise more than $65 million in a stock offering and a private placement as it seeks to come up with a $42 million shortfall stemming from its trade secret spat with Edwards Lifesciences (NYSE:EW) subsidiary CardiAQ Valve. A jury in May 2016 awarded $70 million to CardiAQ after finding that Neovasc misappropriated trade secrets […]
Funding Roundup
Insulet up-sizes and prices $350m private placement
Insulet (NSDQ:PODD) up-sized the private placement that it announced yesterday, citing strong investor demand. The Billerica, Mass.-based company said today it plans to offer $350 million in convertible senior notes due in 2024, up from $300 million. Get the full story at our sister site, Drug Delivery Business News.
NanoVibronix pulls down $5m from public offering
NanoVibronix (NSDQ:NAOV) said today that it pulled down more than $5 million from a public stock offering for its Surface Acoustic Wave antimicrobial platform. The Elmsford, N.Y.-based company said the $4.90-per-share offering, of 1.2 million shares of common stock with warrants to purchase an additional 918,366 shares, grossed $6 million, delivering $5.1 million in net proceeds. Those […]
Insulet to offer $300m in senior convertible notes as part of private placement
Insulet (NSDQ:PODD) said today that it plans to offer $300 million in convertible senior notes due in 2024 as part of a private placement. The Billerica, Mass.-based company is also slated to give initial purchasers an option to buy an additional $45 million in notes. Get the full story at our sister site, Drug Delivery Business […]
InterRad Medical raises another $5m for SecuraCath
Interrad Medical last week reported raising another $5 million for its SecuraCath device, saying it hopes to raise $2 million more. SecurAcath is designed with small insertable anchors at the point of catheter entry to keep catheters from moving or coming loose in patients. The attachment device eliminates the need to suture or adhesively attach catheters. […]
Riverfield Surgical Robot Laboratory raises $10m to challenge Intuitive Surgical in Japan
Robot-assisted surgery startup Riverfield Surgical Robot Laboratory reportedly raised more than $10 million (¥1.15 billion) for the Emaro robot-assisted surgery platform it’s developing. Based on technology developed at the Tokyo Institute of Technology, Riverfield plans to have its device on the Japanese market by 2020, selling at half the price of the da Vinci robot […]
HighLife Medical raises $14m for transcatheter mitral valve replacement
HighLife Medical said today that it raised more than $14 million for the replacement heart valve it’s developing to treat mitral regurgitation. Paris- and Irvine, Calif.-based HighLife said the €12.3 million round was led by European venture capital shop Soffinova Partners, joined by prior backers LivaNova (NSDQ:LIVN) and HighLife founder & CEO Georg Börtlein – who also co-founded […]
CorInnova raises $6m for EpicHeart soft robotic heart failure treatment
CorInnova said today that it raised $6.1 million from Wellcome Trust for the EpicHeart device it’s developing to treat heart failure. Houston-based CorInnova said EpicHeart is a direct cardiac compression device that uses a collapsible, thin-film, pneumatically actuated soft robotic device to surround both ventricles of the heart. It’s designed to use air to inflate and […]
Pacira to invest up to $25m in surgical reconstruction company
Pacira Pharmaceuticals (NSDQ:PCRX) plans to invest up to $25 million in privately-held surgical reconstruction company Tela Bio, the company said today. Pennsylvania-based Tela Bio has a portfolio of reinforced bioscaffold products, called OviTex, which combine biologic and synthetic materials in an embroidered implant that allows fluid and cells to move freely through the device. The implants […]
Siemens taps banks for upcoming Healthineers IPO
Siemens (NYSE:SI) reportedly tapped a trio of banks for the upcoming initial public offering for its Healthineers business. The IPO, which could wind up being one of the largest German flotations in years, is slated to go live during the first half of 2018, Reuters reported. The industrial conglomerate named Goldman Sachs, Deutsche Bank and JP Morgan […]
Lumicell raises $21m for image-guided cancer surgery tech
Lumicell has raised $20.7 million over the past three months, according to a regulatory document filed with SEC last week. More than 20 investors have contributed to the $26.5 million equity offering, the Wellesley, Mass.-based company reported, including one investor outside of the U.S. Get the full story at our sister site, Drug Delivery Business News.